Press Enter or click the Search button above to view results.

Recent Drug Updates

  • nusinersen (Spinraza) FDA approves an antisense oligonucleotide for spinal muscular atrophy in pediatric and adult patients
  • rucaparib (Rubraca) FDA approves PARP inhibitor for women with deleterious BRCA mutation associated with advanced ovarian cancer who have been treated with two or more chemotherapies
  • crisaborole topical (Eucrisa) FDA approves phosphodiesterase (PDE)-4 inhibitor for eczema